
Haejin S. Park
Examiner (ID: 18874, Phone: (571)270-5258 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1614, 1611, 1615 |
| Total Applications | 838 |
| Issued Applications | 413 |
| Pending Applications | 118 |
| Abandoned Applications | 336 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13409937
[patent_doc_number] => 20180256511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => CLATHRIN THERAPEUTIC FOR NEUROPSYCHIATRIC DISEASES & DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/987568
[patent_app_country] => US
[patent_app_date] => 2018-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32416
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15987568
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/987568 | CLATHRIN THERAPEUTIC FOR NEUROPSYCHIATRIC DISEASES & DISORDERS | May 22, 2018 | Abandoned |
Array
(
[id] => 15175135
[patent_doc_number] => 20190358159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => TABLETED CHEWING GUM SUITABLE FOR ACTIVE PHARMACEUTICAL INGREDIENTS
[patent_app_type] => utility
[patent_app_number] => 15/986362
[patent_app_country] => US
[patent_app_date] => 2018-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18567
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15986362
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/986362 | Tableted chewing gum suitable for active pharmaceutical ingredients | May 21, 2018 | Issued |
Array
(
[id] => 16648660
[patent_doc_number] => 10925814
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-23
[patent_title] => Cream gels comprising at least one retinoid and benzoyl peroxide
[patent_app_type] => utility
[patent_app_number] => 15/985190
[patent_app_country] => US
[patent_app_date] => 2018-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7497
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15985190
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/985190 | Cream gels comprising at least one retinoid and benzoyl peroxide | May 20, 2018 | Issued |
Array
(
[id] => 15144761
[patent_doc_number] => 20190350858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => ORAL TABLET FOR DELIVERY OF ACTIVE INGREDIENTS TO THE GASTROINTESTINAL TRACT
[patent_app_type] => utility
[patent_app_number] => 15/982593
[patent_app_country] => US
[patent_app_date] => 2018-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15665
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15982593
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/982593 | ORAL TABLET FOR DELIVERY OF ACTIVE INGREDIENTS TO THE GASTROINTESTINAL TRACT | May 16, 2018 | Abandoned |
Array
(
[id] => 17133623
[patent_doc_number] => 11135157
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Oral tablet for delivery of active ingredients to the throat
[patent_app_type] => utility
[patent_app_number] => 15/982970
[patent_app_country] => US
[patent_app_date] => 2018-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 10
[patent_no_of_words] => 15361
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15982970
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/982970 | Oral tablet for delivery of active ingredients to the throat | May 16, 2018 | Issued |
Array
(
[id] => 15144765
[patent_doc_number] => 20190350860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => Oral Tablet Suitable For Active Pharmaceutical Ingredients
[patent_app_type] => utility
[patent_app_number] => 15/982772
[patent_app_country] => US
[patent_app_date] => 2018-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15982772
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/982772 | Oral tablet suitable for active pharmaceutical ingredients | May 16, 2018 | Issued |
Array
(
[id] => 16650045
[patent_doc_number] => 10927209
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-23
[patent_title] => Polyurethane, urethane-(meth)acrylic composite resin, and aqueous dispersion of urethane-(meth)acrylic composite resin
[patent_app_type] => utility
[patent_app_number] => 15/947043
[patent_app_country] => US
[patent_app_date] => 2018-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 26646
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15947043
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/947043 | Polyurethane, urethane-(meth)acrylic composite resin, and aqueous dispersion of urethane-(meth)acrylic composite resin | Apr 5, 2018 | Issued |
Array
(
[id] => 15738273
[patent_doc_number] => 20200108024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => RISPERIDONE-CONTAINING PATCH
[patent_app_type] => utility
[patent_app_number] => 16/500446
[patent_app_country] => US
[patent_app_date] => 2018-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16196
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500446
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/500446 | Risperidone-containing patch | Apr 3, 2018 | Issued |
Array
(
[id] => 18460370
[patent_doc_number] => 11684648
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-27
[patent_title] => Synergistic herbal compositions for testosterone boosting
[patent_app_type] => utility
[patent_app_number] => 16/492473
[patent_app_country] => US
[patent_app_date] => 2018-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 17888
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16492473
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/492473 | Synergistic herbal compositions for testosterone boosting | Mar 7, 2018 | Issued |
Array
(
[id] => 13354397
[patent_doc_number] => 20180228738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => DEVICE AND METHOD OF TREATING CONDITIONS ASSOCIATED WITH NEUROINFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 15/912103
[patent_app_country] => US
[patent_app_date] => 2018-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15912103
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/912103 | Device and method of treating conditions associated with neuroinflammation | Mar 4, 2018 | Issued |
Array
(
[id] => 13311139
[patent_doc_number] => 20180207106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => PROTEIN COATING COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 15/904949
[patent_app_country] => US
[patent_app_date] => 2018-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32415
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15904949
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/904949 | PROTEIN COATING COMPOSITION | Feb 25, 2018 | Abandoned |
Array
(
[id] => 12881029
[patent_doc_number] => 20180185518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => METHOD FOR CELL ENERGY THERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 15/902081
[patent_app_country] => US
[patent_app_date] => 2018-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60207
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15902081
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/902081 | METHOD FOR CELL ENERGY THERAPEUTICS | Feb 21, 2018 | Abandoned |
Array
(
[id] => 13898687
[patent_doc_number] => 20190038548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => Compositions for respiratory delivery of active agents and associated methods and systems
[patent_app_type] => utility
[patent_app_number] => 15/932249
[patent_app_country] => US
[patent_app_date] => 2018-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30466
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15932249
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/932249 | Compositions for respiratory delivery of active agents and associated methods and systems | Feb 15, 2018 | Abandoned |
Array
(
[id] => 15960519
[patent_doc_number] => 20200164011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => SPORODERM-REMOVED GANODERMA LUCIDUM SPORE POWDER, GRANULE AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/604375
[patent_app_country] => US
[patent_app_date] => 2018-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604375
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/604375 | Sporoderm-removed | Feb 5, 2018 | Issued |
Array
(
[id] => 12831793
[patent_doc_number] => 20180169103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => METHODS OF IMPROVING MYOCARDIAL PERFORMANCE IN FONTAN PATIENTS USING UDENAFIL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 15/887523
[patent_app_country] => US
[patent_app_date] => 2018-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25288
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15887523
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/887523 | Methods of improving myocardial performance in Fontan patients using udenafil compositions | Feb 1, 2018 | Issued |
Array
(
[id] => 13339515
[patent_doc_number] => 20180221297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => System and Method for Improving Adhesion of Transdermal Delivery Devices
[patent_app_type] => utility
[patent_app_number] => 15/887345
[patent_app_country] => US
[patent_app_date] => 2018-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11171
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15887345
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/887345 | System and Method for Improving Adhesion of Transdermal Delivery Devices | Feb 1, 2018 | Abandoned |
Array
(
[id] => 12746485
[patent_doc_number] => 20180140662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => Sustained Release Formulation Comprising Octreotide and Two or More Polylactide-co-glycolide Polymers
[patent_app_type] => utility
[patent_app_number] => 15/873473
[patent_app_country] => US
[patent_app_date] => 2018-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4543
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15873473
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/873473 | Sustained Release Formulation Comprising Octreotide and Two or More Polylactide-co-glycolide Polymers | Jan 16, 2018 | Abandoned |
Array
(
[id] => 16861791
[patent_doc_number] => 11020513
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-01
[patent_title] => Insertable medical devices having microparticulate-associated elastic substrates and methods for drug delivery
[patent_app_type] => utility
[patent_app_number] => 15/866930
[patent_app_country] => US
[patent_app_date] => 2018-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 19
[patent_no_of_words] => 14899
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15866930
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/866930 | Insertable medical devices having microparticulate-associated elastic substrates and methods for drug delivery | Jan 9, 2018 | Issued |
Array
(
[id] => 15021019
[patent_doc_number] => 20190321514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => BONE GRAFT SUBSTITUTE
[patent_app_type] => utility
[patent_app_number] => 16/471107
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16471107
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/471107 | BONE GRAFT SUBSTITUTE | Dec 19, 2017 | Pending |
Array
(
[id] => 15021019
[patent_doc_number] => 20190321514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => BONE GRAFT SUBSTITUTE
[patent_app_type] => utility
[patent_app_number] => 16/471107
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16471107
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/471107 | BONE GRAFT SUBSTITUTE | Dec 19, 2017 | Pending |